CD63 Antibody (TS63) - Azide and BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-14609
![Western Blot: CD63 Antibody (TS63)Azide and BSA Free [NBP3-14609] Western Blot: CD63 Antibody (TS63)Azide and BSA Free [NBP3-14609]](https://resources.bio-techne.com/images/products/CD63-Antibody-TS63-Azide-and-BSA-Free-Western-Blot-NBP3-14609-img0001.jpg)
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry, Immunoprecipitation, Western Blot
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG1 kappa Clone # TS63
Format
Azide and BSA Free
Concentration
1 mg/ml
Product Specifications
Immunogen
Jurkat and HEL cell lines
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Description
Stable at 4C for 12 months.
Hybridoma: Myeloma X63/AG8. x Balb/c spleen cells
Hybridoma: Myeloma X63/AG8. x Balb/c spleen cells
Scientific Data Images for CD63 Antibody (TS63) - Azide and BSA Free
Western Blot: CD63 Antibody (TS63)Azide and BSA Free [NBP3-14609]
Western Blot: CD63 Antibody (TS63) - Azide and BSA Free [NBP3-14609] - 1,3 10^5 HEL cells were lysed (lysis buffer containing 1% Brij97 or triton) Migration SDS/page 5-15% gel under non-reducing conditions.Applications for CD63 Antibody (TS63) - Azide and BSA Free
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Western blot under non-reducing conditions
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS. Sterile-filtered through 0.22 um.
Format
Azide and BSA Free
Preservative
No Preservative
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: CD63
References
1. Pols, M. S., & Klumperman, J. (2009). Trafficking and function of the tetraspanin CD63. Experimental cell research. https://doi.org/10.1016/j.yexcr.2008.09.020
2. Metzelaar, M. J., Wijngaard, P. L., Peters, P. J., Sixma, J. J., Nieuwenhuis, H. K., & Clevers, H. C. (1991). CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. The Journal of biological chemistry.
3. Horejsi, V., & Vlcek, C. (1991). Novel structurally distinct family of leucocyte surface glycoproteins including CD9, CD37, CD53 and CD63. FEBS letters. https://doi.org/10.1016/0014-5793(91)80988-f
4. Eckfeld, C., HauBler, D., Schoeps, B., Hermann, C. D., & Kruger, A. (2019). Functional disparities within the TIMP family in cancer: hints from molecular divergence. Cancer metastasis reviews. https://doi.org/10.1007/s10555-019-09812-6
5. Hoffmann, H. J., Santos, A. F., Mayorga, C., Nopp, A., Eberlein, B., Ferrer, M., Rouzaire, P., Ebo, D. G., Sabato, V., Sanz, M. L., Pecaric-Petkovic, T., Patil, S. U., Hausmann, O. V., Shreffler, W. G., Korosec, P., & Knol, E. F. (2015). The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease. Allergy. https://doi.org/10.1111/all.12698
6. Dell'Angelica, E. C., Shotelersuk, V., Aguilar, R. C., Gahl, W. A., & Bonifacino, J. S. (1999). Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the beta 3A subunit of the AP-3 adaptor. Molecular cell. https://doi.org/10.1016/s1097-2765(00)80170-7
Alternate Names
CD63, Granulophysin, Lamp-3, ME491, OMA81H, Tspan30
Gene Symbol
CD63
Additional CD63 Products
Product Documents for CD63 Antibody (TS63) - Azide and BSA Free
Product Specific Notices for CD63 Antibody (TS63) - Azide and BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...